A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.
Cells, Free Full-Text
Scientists harness human protein to deliver molecular medicines to cells, MIT News
New Cas9 mouse model will be easier to CRISPR gene-edit and enable faster progress against diseases like cancer
CRISPR-edited immune cells can be safely given to cancer patients
Nanoparticles can Perform Gene-editing in the Lungs - The Indian Practitioner
Researchers develop new mRNA-based delivery technology for gene editing in the lungs
Nanoparticles used to deliver CRISPR gene editing tools into the cell
Gene-editing technique could speed up study of cancer mutations, MIT News
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing
New Type of Nanoparticle Can Perform Gene Editing in the Lungs
Nanosensors Enable Urine Test for Lung Cancer
Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models
gene editing – Page 2 – NIH Director's Blog
Nanoparticles: Precision Targeting of Drug Directly into the Lungs